Discontinued — last reported Q4 '25
International Business Machines Acquisitions increased by 2576.5% to $10.47B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 47.4%, from $7.10B to $10.47B. Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 26.0% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.75B | $152.00M | $275.00M | $698.00M | $260.00M | $62.00M | $1.33B | $22.00M | $334.00M | $4.59B | $137.00M | $82.00M | $153.00M | $2.51B | $541.00M | $7.10B | $747.00M | $58.00M | $391.00M | $10.47B |
| QoQ Change | — | -91.3% | +80.9% | +153.8% | -62.8% | -76.2% | >999% | -98.3% | >999% | >999% | -97.0% | -40.1% | +86.6% | >999% | -78.5% | >999% | -89.5% | -92.2% | +574.1% | >999% |
| YoY Change | — | — | — | — | -85.1% | -59.2% | +382.9% | -96.8% | +28.5% | >999% | -89.7% | +272.7% | -54.2% | -45.2% | +294.9% | >999% | +388.2% | -97.7% | -27.7% | +47.4% |